NCT05087251Active, not recruiting
The Transitions Project: Efficacy Trial
Randomized Trial of an Intervention to Enhance Quality of Life in Adults Completing Lung Cancer Treatment With Curative Intent
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 1 Oct 2021
- Start date
- 30 Sept 2021
- Primary completion date
- 15 Jun 2024
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Lung cancer
- NCT number
- NCT05087251
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 30 Sept 2021 to the primary completion date, 15 Jun 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current participation in cognitive behavioral therapy treatment
Other illness
- Comorbid health condition that would interfere with study participation
Who the study is looking for
- Age 21 or older
- Able to read and respond in English
- Diagnosis of non-small cell lung cancer or small cell lung cancer
- Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery
- Completed cancer treatment within past 3 weeks
- If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete
- If final treatment is surgery: within 3 weeks after hospital discharge following surgery
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Cancer Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.